US Stock MarketDetailed Quotes

Aprea Therapeutics (APRE)

Watchlist
  • 0.7468
  • -0.0182-2.38%
Trading Jun 12 09:45 ET
9.25MMarket Cap-0.50P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aprea Therapeutics (APRE) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
24.08%-2.76M
4.89%-12.89M
15.65%-2.96M
-28.48%-3.17M
14.03%-3.13M
7.74%-3.63M
-11.32%-13.56M
6.12%-3.51M
-10.10%-2.47M
-13.20%-3.64M
Net income from continuing operations
16.39%-3.29M
2.77%-12.6M
15.17%-2.46M
21.44%-2.97M
6.66%-3.24M
-39.95%-3.93M
9.30%-12.96M
15.93%-2.89M
-18.08%-3.78M
-6.47%-3.47M
Operating gains losses
-114.89%-7.71K
232.76%95.32K
115.37%8.7K
-83.97%5.69K
429.33%29.12K
192.22%51.8K
-284.45%-71.8K
-172.02%-56.62K
1,132.43%35.49K
109.76%5.5K
Depreciation and amortization
-0.02%5.43K
-2.70%21.72K
0.02%5.43K
0.00%5.43K
2.34%5.43K
-11.82%5.43K
216.48%22.32K
8.86%5.43K
279.12%5.43K
2,267.86%5.3K
Other non cash items
----
123.97%39.05K
----
----
----
----
--17.44K
----
----
----
Change In working capital
244.19%432.41K
11.97%-929.1K
5.72%-667.87K
-128.76%-323.69K
79.68%-63.17K
110.82%125.63K
-165.20%-1.06M
-53.04%-708.38K
27.57%1.13M
-81.80%-310.86K
-Change in prepaid assets
0.40%181.78K
-125.40%-217.91K
-48.55%-735.65K
-72.66%170K
138.15%166.71K
-15.26%181.04K
-121.39%-96.67K
20.79%-495.21K
-6.76%621.83K
-760.13%-436.94K
-Change in payables and accrued expense
552.28%250.63K
-65.49%-711.19K
131.80%67.79K
-189.05%-493.69K
-202.74%-229.87K
94.43%-55.41K
-167.39%-429.75K
41.87%-213.17K
157.47%554.37K
194.33%223.74K
-Change in other working capital
----
----
----
----
----
----
-200.00%-528.97K
--0
---50.74K
---97.67K
Cash from discontinued investing activities
Operating cash flow
24.08%-2.76M
4.89%-12.89M
15.65%-2.96M
-28.48%-3.17M
14.03%-3.13M
7.74%-3.63M
-11.32%-13.56M
6.12%-3.51M
-10.10%-2.47M
-13.20%-3.64M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
0
0
83.37%-15.48K
0
0
-7.5K
Net PPE purchase and sale
----
--0
--0
--0
--0
--0
83.37%-15.48K
--0
--0
---7.5K
Cash from discontinued investing activities
Investing cash flow
----
--0
--0
--0
--0
--0
83.37%-15.48K
--0
--0
---7.5K
Financing cash flow
Cash flow from continuing financing activities
61,896.01%34.62M
-68.69%4.64M
2,758.20%3.84M
31,090.48%357.94K
1,927.54%384.88K
-99.62%55.85K
188.36%14.82M
134.41K
-1.16K
-21.06K
Net common stock issuance
59,154.50%35.1M
-68.73%5.05M
2,893.23%4.21M
--375.38K
--399.79K
-99.63%59.23K
178.81%16.14M
--140.76K
--0
--0
Proceeds from stock option exercised by employees
----
--91
----
----
----
----
--0
----
----
----
Net other financing activities
-13,922.57%-474.66K
69.10%-407.46K
-5,751.25%-371.73K
-1,409.78%-17.44K
29.22%-14.91K
99.74%-3.39K
-103.18%-1.32M
---6.35K
---1.16K
---21.06K
Cash from discontinued financing activities
Financing cash flow
61,896.01%34.62M
-68.69%4.64M
2,758.20%3.84M
31,090.48%357.94K
1,927.54%384.88K
-99.62%55.85K
188.36%14.82M
--134.41K
---1.16K
---21.06K
Net cash flow
Beginning cash position
-36.04%14.64M
5.74%22.89M
-47.67%13.76M
-42.33%16.57M
-40.40%19.32M
5.74%22.89M
-24.80%21.65M
3.53%26.29M
3.65%28.74M
4.57%32.41M
Current changes in cash
991.32%31.87M
-760.50%-8.25M
126.07%880.28K
-13.92%-2.81M
25.18%-2.75M
-133.21%-3.58M
117.53%1.25M
9.88%-3.38M
-6.08%-2.47M
-14.09%-3.67M
Effect of exchange rate changes
-124.89%-348
165.16%4.68K
105.17%1.27K
-102.43%-600
154.06%2.61K
157.91%1.4K
14.50%-7.18K
-6,525.07%-24.61K
816.80%24.67K
90.98%-4.82K
End cash Position
140.77%46.51M
-36.04%14.64M
-36.04%14.64M
-47.67%13.76M
-42.33%16.57M
-40.40%19.32M
5.74%22.89M
5.74%22.89M
3.53%26.29M
3.65%28.74M
Free cash flow
24.08%-2.76M
4.99%-12.89M
15.65%-2.96M
-28.48%-3.17M
14.21%-3.13M
7.93%-3.63M
-10.61%-13.57M
6.30%-3.51M
-6.03%-2.47M
-13.44%-3.65M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 24.08%-2.76M4.89%-12.89M15.65%-2.96M-28.48%-3.17M14.03%-3.13M7.74%-3.63M-11.32%-13.56M6.12%-3.51M-10.10%-2.47M-13.20%-3.64M
Net income from continuing operations 16.39%-3.29M2.77%-12.6M15.17%-2.46M21.44%-2.97M6.66%-3.24M-39.95%-3.93M9.30%-12.96M15.93%-2.89M-18.08%-3.78M-6.47%-3.47M
Operating gains losses -114.89%-7.71K232.76%95.32K115.37%8.7K-83.97%5.69K429.33%29.12K192.22%51.8K-284.45%-71.8K-172.02%-56.62K1,132.43%35.49K109.76%5.5K
Depreciation and amortization -0.02%5.43K-2.70%21.72K0.02%5.43K0.00%5.43K2.34%5.43K-11.82%5.43K216.48%22.32K8.86%5.43K279.12%5.43K2,267.86%5.3K
Other non cash items ----123.97%39.05K------------------17.44K------------
Change In working capital 244.19%432.41K11.97%-929.1K5.72%-667.87K-128.76%-323.69K79.68%-63.17K110.82%125.63K-165.20%-1.06M-53.04%-708.38K27.57%1.13M-81.80%-310.86K
-Change in prepaid assets 0.40%181.78K-125.40%-217.91K-48.55%-735.65K-72.66%170K138.15%166.71K-15.26%181.04K-121.39%-96.67K20.79%-495.21K-6.76%621.83K-760.13%-436.94K
-Change in payables and accrued expense 552.28%250.63K-65.49%-711.19K131.80%67.79K-189.05%-493.69K-202.74%-229.87K94.43%-55.41K-167.39%-429.75K41.87%-213.17K157.47%554.37K194.33%223.74K
-Change in other working capital -------------------------200.00%-528.97K--0---50.74K---97.67K
Cash from discontinued investing activities
Operating cash flow 24.08%-2.76M4.89%-12.89M15.65%-2.96M-28.48%-3.17M14.03%-3.13M7.74%-3.63M-11.32%-13.56M6.12%-3.51M-10.10%-2.47M-13.20%-3.64M
Investing cash flow
Cash flow from continuing investing activities 0000083.37%-15.48K00-7.5K
Net PPE purchase and sale ------0--0--0--0--083.37%-15.48K--0--0---7.5K
Cash from discontinued investing activities
Investing cash flow ------0--0--0--0--083.37%-15.48K--0--0---7.5K
Financing cash flow
Cash flow from continuing financing activities 61,896.01%34.62M-68.69%4.64M2,758.20%3.84M31,090.48%357.94K1,927.54%384.88K-99.62%55.85K188.36%14.82M134.41K-1.16K-21.06K
Net common stock issuance 59,154.50%35.1M-68.73%5.05M2,893.23%4.21M--375.38K--399.79K-99.63%59.23K178.81%16.14M--140.76K--0--0
Proceeds from stock option exercised by employees ------91------------------0------------
Net other financing activities -13,922.57%-474.66K69.10%-407.46K-5,751.25%-371.73K-1,409.78%-17.44K29.22%-14.91K99.74%-3.39K-103.18%-1.32M---6.35K---1.16K---21.06K
Cash from discontinued financing activities
Financing cash flow 61,896.01%34.62M-68.69%4.64M2,758.20%3.84M31,090.48%357.94K1,927.54%384.88K-99.62%55.85K188.36%14.82M--134.41K---1.16K---21.06K
Net cash flow
Beginning cash position -36.04%14.64M5.74%22.89M-47.67%13.76M-42.33%16.57M-40.40%19.32M5.74%22.89M-24.80%21.65M3.53%26.29M3.65%28.74M4.57%32.41M
Current changes in cash 991.32%31.87M-760.50%-8.25M126.07%880.28K-13.92%-2.81M25.18%-2.75M-133.21%-3.58M117.53%1.25M9.88%-3.38M-6.08%-2.47M-14.09%-3.67M
Effect of exchange rate changes -124.89%-348165.16%4.68K105.17%1.27K-102.43%-600154.06%2.61K157.91%1.4K14.50%-7.18K-6,525.07%-24.61K816.80%24.67K90.98%-4.82K
End cash Position 140.77%46.51M-36.04%14.64M-36.04%14.64M-47.67%13.76M-42.33%16.57M-40.40%19.32M5.74%22.89M5.74%22.89M3.53%26.29M3.65%28.74M
Free cash flow 24.08%-2.76M4.99%-12.89M15.65%-2.96M-28.48%-3.17M14.21%-3.13M7.93%-3.63M-10.61%-13.57M6.30%-3.51M-6.03%-2.47M-13.44%-3.65M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +5.57%
Sample Name
Sample Code
 +0.22%
Sample Name
Sample Code
 -1.68%
4
ProShares Ultra Energy
DIG
-1.72%
5
VanEck Oil Services ETF
OIH
-2.49%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.99%
Sample Name
Sample Code
 +10.78%
Sample Name
Sample Code
 +7.54%
4
United Microelectronics
UMC
+7.39%
5
NetEase
NTES
+5.91%
View More
Middle East conflict spreads to the stock market! How should investors respond?
A critical window for U.S.-Iran talks has opened! According to Bloomberg, the U.S. and Iran are 'close' to signing an agreement around the u Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -